Itafos Crecimiento futuro

Future controles de criterios 0/6

Itafos's EPS se espera que grow en 58.8% por año.

Información clave

n/a

Tasa de crecimiento de los beneficios

58.8%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Chemicals	16.0%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

This Analyst Just Made A Massive Upgrade To Their Itafos (CVE:IFOS) Earnings Forecasts

Feb 18

Can You Imagine How Elated Itafos' (CVE:IFOS) Shareholders Feel About Its 743% Share Price Gain?

Dec 17

Previsiones de crecimiento de beneficios e ingresos

TSXV:IFOS - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2023	466	4	40	95	N/A
9/30/2023	482	81	69	112	N/A
6/30/2023	524	86	139	176	N/A
3/31/2023	563	110	138	174	N/A
12/31/2022	593	115	169	208	N/A
9/30/2022	575	109	163	198	N/A
6/30/2022	525	117	112	149	N/A
3/31/2022	473	82	97	134	N/A
12/31/2021	413	51	60	94	N/A
9/30/2021	372	17	38	68	N/A
6/30/2021	316	-12	29	53	N/A
3/31/2021	275	-43	5	19	N/A
12/31/2020	260	-63	-17	-3	N/A
9/30/2020	267	-141	-38	-10	N/A
6/30/2020	301	-148	-30	7	N/A
3/31/2020	342	-149	-23	21	N/A
12/31/2019	339	-144	-12	35	N/A
9/30/2019	359	-211	-16	35	N/A
6/30/2019	353	-204	-44	10	N/A
3/31/2019	317	-178	-58	2	N/A
12/31/2018	302	-113	-82	-19	N/A
9/30/2018	202	34	-79	-24	N/A
6/30/2018	125	39	-68	-20	N/A
3/31/2018	58	27	-77	-36	N/A
12/31/2017	N/A	-30	-64	-26	N/A
9/30/2017	N/A	-63	N/A	-28	N/A
6/30/2017	N/A	-101	N/A	-23	N/A
3/31/2017	N/A	-103	N/A	-16	N/A
12/31/2016	N/A	-101	N/A	-14	N/A
9/30/2016	N/A	-76	N/A	-7	N/A
6/30/2016	N/A	-75	N/A	-5	N/A
3/31/2016	N/A	-79	N/A	-4	N/A
12/31/2015	N/A	-118	N/A	-7	N/A
9/30/2015	N/A	-111	N/A	-4	N/A
6/30/2015	N/A	-84	N/A	-2	N/A
3/31/2015	N/A	-78	N/A	-3	N/A
12/31/2014	N/A	-29	N/A	3	N/A
9/30/2014	N/A	-31	N/A	28	N/A
6/30/2014	N/A	-18	N/A	16	N/A
3/31/2014	N/A	-29	N/A	18	N/A
12/31/2013	N/A	-32	N/A	11	N/A
9/30/2013	1	-23	N/A	-27	N/A
6/30/2013	4	-24	N/A	-11	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de IFOS es superior a la tasa de ahorro (1.9%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de IFOS crezcan más deprisa que el mercado Canadian

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de IFOS crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de IFOS crezcan más rápido que el mercado de Canadian.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de IFOS crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la Rentabilidad de los fondos propios de IFOS se prevé elevada dentro de 3 años.

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Itafos Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Itafos Inc. Narrows its Earnings Guidance for 2023

Itafos Inc. Provides Earnings Guidance for the Year 2023

Consensus EPS estimates increase by 16%

Consensus EPS estimates fall by 26%

Price target decreased to CA$5.25

Itafos Inc. Provides Earnings Guidance for Fiscal Year 2022

Recent updates

Itafos' (CVE:IFOS) Soft Earnings Are Actually Better Than They Appear

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

CEO & Director exercised options to buy CA$84k worth of stock.

Third quarter 2023 earnings released: EPS: US$0.016 (vs US$0.043 in 3Q 2022)

Itafos Inc. Narrows its Earnings Guidance for 2023

Little Excitement Around Itafos Inc.'s (CVE:IFOS) Earnings

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Investor sentiment improves as stock rises 16%

Itafos (CVE:IFOS) Knows How To Allocate Capital Effectively

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Itafos Inc. Provides Earnings Guidance for the Year 2023

Does Itafos (CVE:IFOS) Have A Healthy Balance Sheet?

Itafos Files Updated Feasibility Study for the Farim Phosphate Project

Itafos Inc. Completes Updated Feasibility Study for the Farim Phosphate Project

Consensus EPS estimates increase by 16%

Itafos Inc., Annual General Meeting, Jul 13, 2023

First quarter 2023 earnings released: EPS: US$0.15 (vs US$0.18 in 1Q 2022)

Itafos Announces Notice to Proceed for Husky 1/North Dry Ridge

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 22%

Is Itafos (CVE:IFOS) Using Too Much Debt?

Investor sentiment improves as stock rises 16%

Consensus EPS estimates fall by 26%

Price target decreased to CA$5.25

Itafos Inc. Provides Earnings Guidance for Fiscal Year 2022

Price target decreased to CA$5.25

Investor sentiment deteriorated over the past week

Is Itafos (CVE:IFOS) Using Too Much Debt?

Investor sentiment improved over the past week

Consensus EPS estimates increase by 17%

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Itafos Inc. Appoints Matthew O’Neill as Chief Financial Officer Succeeding George Burdette

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Itafos Inc. Announces Production and Sales of Hydrofluorosilicic Acid at Conda

Investor sentiment improved over the past week

Itafos Inc. Provides Earnings Guidance for the First Half and Second Half of 2022

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

These 4 Measures Indicate That Itafos (CVE:IFOS) Is Using Debt Extensively

Less than half of directors are independent

Itafos Inc., Annual General Meeting, Jun 24, 2022

Itafos Inc. Announces Board Changes

Itafos Inc. Announces Resumption of Sulfuric Acid Production at Arraias

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Second quarter 2021 earnings released: EPS US$0.05 (vs US$0.11 loss in 2Q 2020)

Health Check: How Prudently Does Itafos (CVE:IFOS) Use Debt?

First quarter 2021 earnings released: EPS US$0.01 (vs US$0.10 loss in 1Q 2020)

Is Itafos (CVE:IFOS) Using Debt In A Risky Way?

Full year 2020 earnings released: US$0.34 loss per share (vs US$1.02 loss in FY 2019)

This Analyst Just Made A Massive Upgrade To Their Itafos (CVE:IFOS) Earnings Forecasts

Itafos Appoints David Brush as Chief Strategy Officer

Itafos(TSXV:IFOS) dropped from S&P/TSX Venture Composite Index

New 90-day high: CA$0.52

Itafos Announces Notice of Intent for Conda Mine Life Extension

Can You Imagine How Elated Itafos' (CVE:IFOS) Shareholders Feel About Its 743% Share Price Gain?

Itafos Announces Executive Changes

New 90-day low: CA$0.24

Analysts update estimates

Earnings released

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura